In Vitro Assessments of Antimicrobial Activity

AMENDMENT TWO 

The purpose of Amendment Two is to:

1. Respond to questions received regarding this solicitation.

______________________________________________________________________

AMENDMENT ONE 

The purpose of Amendment One is to:

1. Provide a cut-off date for submission of questions;
2. Provide updated instructions for the Proposal Intent Response Sheet;
3. Clarify submission instructions to eCPS; and
4. Respond to questions received regarding this solicitation.

______________________________________________________________________

Introduction

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research .... Read More

AMENDMENT ONE 

The purpose of Amendment One is to:

1. Provide a cut-off date for submission of questions;
2. Provide updated instructions for the Proposal Intent Response Sheet;
3. Clarify submission instructions to eCPS; and
4. Respond to questions received regarding this solicitation.

______________________________________________________________________

Introduction

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, .... Read More

Introduction

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Microbiology and Infectious Diseases (DMID), has a requirement to support in vitro testing assess the therapeutic potential of compounds to advance our understanding of infectious diseases as well as advance the development of therapeutics for infectious diseases.

Description

Introduction

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Microbiology and Infectious Diseases (DMID), has a requirement to support in vitro testing assess the therapeutic potential of compounds to advance our understanding of infectious diseases as well as advance the development of therapeutics for infectious diseases.

Description